Opportunity, satisfaction, and regret: Trying long-acting reversible contraception in a unique scientific circumstance
- PMID: 29920171
- DOI: 10.1080/03630242.2018.1478363
Opportunity, satisfaction, and regret: Trying long-acting reversible contraception in a unique scientific circumstance
Abstract
Increased use of long-acting reversible contraception (LARC) can reduce unintended pregnancies. However, significant barriers exist to LARC uptake, particularly high up-front costs. In North Carolina in 2014, we interviewed thirty-four purposively selected participants (aged 20-30 years) enrolled in a partially randomized patient preference trial to learn about their experiences with and attitudes toward contraception in this unique trial context. Cost of LARC was important in participants' decision-making. Experiencing an unintended pregnancy motivated women to switch to LARC. No participants who tried LARC, even those who experienced side effects, regretted it. Several participants regretted discontinuing their LARC. Concerns about insertion and removal did not influence future willingness to try LARC. Participants discussed the importance of affordability and feeling in control when choosing a contraceptive method. Cost, combined with uncertainty over whether LARC is the right method for them, may deter young women from trying LARC. Intrauterine devices (IUDs) and implants should be made affordable so that women can try them without significant financial commitment. Affordability will likely increase uptake, which will reduce unintended pregnancies. Regret from discontinuing LARC was more frequently reported than regret from trying LARC. Providers should offer young women LARC and counsel to support continuation.
Trial registration: ClinicalTrials.gov NCT01299116.
Keywords: Adolescent; attitudes; beliefs; contraception; cost; long-acting reversible contraception; regret; young women.
Similar articles
-
Not seeking yet trying long-acting reversible contraception: a 24-month randomized trial on continuation, unintended pregnancy and satisfaction.Contraception. 2018 Jun;97(6):524-532. doi: 10.1016/j.contraception.2018.02.001. Epub 2018 Feb 19. Contraception. 2018. PMID: 29470950 Free PMC article. Clinical Trial.
-
Rationale and enrollment results for a partially randomized patient preference trial to compare continuation rates of short-acting and long-acting reversible contraception.Contraception. 2015 Mar;91(3):185-92. doi: 10.1016/j.contraception.2014.11.006. Epub 2014 Nov 15. Contraception. 2015. PMID: 25500324 Free PMC article. Clinical Trial.
-
Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods: a randomized patient preference trial.Am J Obstet Gynecol. 2017 Feb;216(2):101-109. doi: 10.1016/j.ajog.2016.08.033. Epub 2016 Sep 20. Am J Obstet Gynecol. 2017. PMID: 27662799 Free PMC article. Clinical Trial.
-
Current barriers and potential strategies to increase the use of long-acting reversible contraception (LARC) to reduce the rate of unintended pregnancies in Australia: An expert roundtable discussion.Aust N Z J Obstet Gynaecol. 2017 Apr;57(2):206-212. doi: 10.1111/ajo.12587. Epub 2017 Mar 10. Aust N Z J Obstet Gynaecol. 2017. PMID: 28294293
-
Current evidence of contraceptive uptake, pregnancy and continuation rates in young women: a systematic review and Meta-analysis.Eur J Contracept Reprod Health Care. 2020 Dec;25(6):492-501. doi: 10.1080/13625187.2020.1833187. Eur J Contracept Reprod Health Care. 2020. PMID: 33140990
Publication types
MeSH terms
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical